Catalogo dei prodotti della ricerca

TINI MELATO, Giacomo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.772
AS - Asia 3.488
EU - Europa 2.252
SA - Sud America 587
Continente sconosciuto - Info sul continente non disponibili 477
AF - Africa 145
OC - Oceania 26
Totale 10.747
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.535
IT - Italia 1.244
SG - Singapore 1.221
HK - Hong Kong 553
CN - Cina 508
BR - Brasile 454
VN - Vietnam 409
BD - Bangladesh 204
DE - Germania 201
IN - India 164
FR - Francia 123
CA - Canada 121
FI - Finlandia 116
IE - Irlanda 111
GB - Regno Unito 99
JP - Giappone 79
RU - Federazione Russa 77
ID - Indonesia 69
NL - Olanda 62
KR - Corea 61
AT - Austria 52
AR - Argentina 51
MA - Marocco 46
IQ - Iraq 44
ZA - Sudafrica 44
MX - Messico 36
SE - Svezia 30
AU - Australia 26
TR - Turchia 24
PH - Filippine 20
BG - Bulgaria 19
CR - Costa Rica 18
PL - Polonia 18
PK - Pakistan 17
VE - Venezuela 17
CO - Colombia 16
EC - Ecuador 16
ES - Italia 15
JM - Giamaica 15
MY - Malesia 13
EG - Egitto 12
UZ - Uzbekistan 12
CH - Svizzera 10
CL - Cile 10
HN - Honduras 10
AE - Emirati Arabi Uniti 9
GR - Grecia 9
PY - Paraguay 9
BE - Belgio 8
KE - Kenya 8
LT - Lituania 8
NO - Norvegia 8
NP - Nepal 8
SA - Arabia Saudita 8
TH - Thailandia 8
GE - Georgia 7
PE - Perù 7
PT - Portogallo 7
EE - Estonia 6
IR - Iran 6
TT - Trinidad e Tobago 6
UA - Ucraina 6
GT - Guatemala 5
IL - Israele 5
OM - Oman 5
RO - Romania 5
SC - Seychelles 5
CI - Costa d'Avorio 4
DO - Repubblica Dominicana 4
JO - Giordania 4
LB - Libano 4
NG - Nigeria 4
NI - Nicaragua 4
PS - Palestinian Territory 4
TN - Tunisia 4
TW - Taiwan 4
UY - Uruguay 4
AL - Albania 3
AM - Armenia 3
BY - Bielorussia 3
ET - Etiopia 3
PR - Porto Rico 3
SV - El Salvador 3
AO - Angola 2
AZ - Azerbaigian 2
BH - Bahrain 2
BO - Bolivia 2
BS - Bahamas 2
CZ - Repubblica Ceca 2
DM - Dominica 2
DZ - Algeria 2
GA - Gabon 2
GH - Ghana 2
HR - Croazia 2
HU - Ungheria 2
KW - Kuwait 2
MM - Myanmar 2
RS - Serbia 2
SN - Senegal 2
AW - Aruba 1
Totale 10.246
Salva come PNG Salva come JPEG
Città #
Singapore 717
Hong Kong 528
San Jose 505
Ashburn 463
Rome 379
Dallas 253
Milan 252
Los Angeles 183
Ho Chi Minh City 149
Hefei 125
Council Bluffs 123
New York 123
Santa Clara 109
Buffalo 102
Dublin 96
Hanoi 95
Beijing 86
Lauterbourg 86
Munich 65
Tokyo 65
Redondo Beach 52
The Dalles 51
Jakarta 48
Boardman 47
Helsinki 47
Hillsboro 47
São Paulo 46
Casablanca 41
Frankfurt am Main 41
Johannesburg 38
Figino 37
Phoenix 37
Vienna 35
Lappeenranta 34
Nuremberg 33
Seoul 33
Turku 33
Fairfield 31
Toronto 28
Atlanta 25
Montreal 25
Houston 24
Denver 22
Seattle 22
Frisco 19
Orem 19
Bologna 18
Chandler 18
Naples 18
Rio de Janeiro 18
Chicago 17
San Francisco 17
Sofia 17
Cambridge 16
Baghdad 15
Brooklyn 15
Mexico City 15
Woodbridge 15
Bengaluru 14
Cosenza 13
Florence 13
Ottawa 13
San José 13
Da Nang 12
London 12
Washington 12
Adelaide 11
Princeton 11
Shanghai 11
Tashkent 11
Turin 11
Wilmington 11
Bari 10
Falkenstein 10
Haiphong 10
Poplar 10
Boston 9
Guangzhou 9
Moscow 9
Piscataway 9
Warsaw 9
Amsterdam 8
Biên Hòa 8
Columbus 8
Des Moines 8
Genoa 8
Istanbul 8
Nairobi 8
Nellore 8
San Paolo di Civitate 8
Tianjin 8
Ankara 7
Belo Horizonte 7
Brisbane 7
Campo Grande 7
Can Tho 7
Chennai 7
Kingston 7
Lahore 7
Mumbai 7
Totale 6.014
Salva come PNG Salva come JPEG
Nome #
Arrhythmic stratification of cardiac amyloidosis: state of the art 289
A Novel Nonsense Pathogenic TTN Variant Identified in a Patient with Severe Dilated Cardiomyopathy 246
Long-term management of Takotsubo syndrome: a not-so-benign condition 229
Pulmonary hypertension and clinical correlates in hypertrophic cardiomyopathy 206
Role of Arterial Hypertension and Hypertension-Mediated Organ Damage in Cardiotoxicity of Anticancer Therapies 189
Clinical translation of genetic testing in TTR Amyloidosis. genotype-phenotype correlations, management of asymptomatic carriers and familial screening 170
Long QTc in hypertrophic cardiomyopathy. A consequence of structural myocardial damage or a distinct genetic disease? 168
Risk stratification in transthyretin-related cardiac amyloidosis 165
Novel Imaging and Genetic Risk Markers in Takotsubo Syndrome 162
Association between Immune Checkpoint Inhibitors and Atherosclerotic Cardiovascular Disease Risk. Another Brick in the Wall 160
Cardiac magnetic resonance imaging in immune check-point inhibitor myocarditis: a systematic review 158
Re-analysis of next-generation sequencing data in patients with hypertrophic cardiomyopathy: contribution of spliceogenic MYBPC3 variants in an italian cohort 149
Management of overlapping immune-related myocarditis, myositis, and myasthenia in a young patient with advanced NSCLC: a case report 148
Clinical characteristics and outcomes of Takotsubo syndrome in patients with chronic obstructive pulmonary disease 138
Long-Term Outcome of Acute Coronary Syndromes in Young Patients 138
Prognostic impact of hypertension and diabetes in patients with cardiac amyloidosis 129
A contemporary update on cancer and takotsubo syndrome 129
A systematic review on focal takotsubo syndrome. a not-so-small matter 128
Association between immune checkpoint inhibitors and atherosclerotic cardiovascular disease risk: another brick in the wall 126
MYBPC3 c.2309-2A>G: exploring a founder variant in Italian hypertrophic cardiomyopathy patients 126
Update on the diagnosis and treatment of pericardial diseases: a position paper of the Italian Society of Cardiology in collaboration with the study group on cardiomyopathies and pericardial diseases 126
Prognostic impact of different triggers in patients with Takotsubo syndrome and chronic obstructive pulmonary disease. Author's reply 125
Exploring the influence of takotsubo syndrome on oncologic patients' mortality 124
Unveiling the future of cardiac care: a review of gene therapy in cardiomyopathies 124
Long-Term Left Ventricular Remodeling of Patients With Hypertrophic Cardiomyopathy 122
Left ventricular remodeling in hypertrophic cardiomyopathy: an overview of current knowledge 121
Diagnostic pathways to wild-type transthyretin amyloid cardiomyopathy. a multicentre network study 121
Impact of the noninvasive diagnostic algorithm on clinical presentation and prognosis in cardiac amyloidosis 120
Prognostic implications of different clinical profiles in hypertrophic cardiomyopathy 120
New Insights on the Toxicity on Heart and Vessels of Breast Cancer Therapies 116
Guideline-directed medical therapy in patients with heart failure with reduced ejection fraction and incident cancer 115
Relation of delayed intrinsicoid deflection of the QRS complex to sudden cardiac death in patients with hypertrophic cardiomyopathy 113
Clinical characteristics and outcome of end stage hypertrophic cardiomyopathy. Role of age and heart failure phenotypes 110
Arterial hypertension in cancer: the elephant in the room 109
Advanced cardiovascular magnetic resonance imaging in takotsubo syndrome: update on feature tracking and tissue mapping 108
Acute Myocarditis Associated With Desmosomal Gene Variants 105
Substrates of sudden cardiac death in hypertrophic cardiomyopathy 102
Alzheimer's Disease and Cardiovascular Disease. A Particular Association 102
Cancer patient with unusual dyspnea in the COVID-19 era: challenging management of a rare cardiac tumor 101
Electrocardiographic changes in focal takotsubo syndrome. a case report 101
Critical approach to the 2023 European Society of Cardiology guidelines on cardiomyopathies: a document by the Working Group on myocardial and pericardial diseases of the Italian Society of Cardiology 100
Baseline cardio-oncologic risk assessment in breast cancer women and occurrence of cardiovascular events. The HFA/ICOS risk tool in real-world practice 100
High-sensitivity cardiac Troponin I for risk stratification in wild-type transthyretin amyloid cardiomyopathy 100
Early diagnosis, disease stage and prognosis in wild-type transthyretin amyloid cardiomyopathy: The DIAMOND study 98
Prevalence and prognostic role of nonsustained ventricular tachycardia in cardiac amyloidosis 96
Anthracyclines-Induced Cardiac Dysfunction. What Every Clinician Should Know 96
Incidence and determinants of atrial fibrillation in patients with wild-type transthyretin cardiac amyloidosis 95
Electrocardiographic heterogeneity of patients with variant transthyretin amyloid cardiomyopathy: genotype-phenotype correlations 94
A Plea for Smoking-Free Policies in COVID-19 Times: Cardiovascular Prevention as an Ally in Coronavirus Containment 94
Myosin-ATPase inhibitor in real-world patients with obstructive HCM: a report by the cardiomyopathies and pericardial diseases WG of the Italian Society of Cardiology 93
Cancer mortality in trials of heart failure with reduced ejection fraction. A systematic review and meta-analysis 93
Amyloid Cardiomyopathy in the Rare Transthyretin Tyr78Phe Mutation 93
null 91
The impossible quest to make cardiac amyloidosis diagnosis easy 89
Real-world candidacy to mavacamten in a contemporary hypertrophic obstructive cardiomyopathy population 89
Diagnostic Delay in Arrhythmogenic Cardiomyopathy 86
Incidence and risk factors for pacemaker implantation in light-chain and transthyretin cardiac amyloidosis 86
Exercise limitations in amyloid cardiomyopathy assessed by cardiopulmonary exercise testing—A multicentre study 86
Yield of bone scintigraphy screening for transthyretin-related cardiac amyloidosis in different conditions. Methodological issues and clinical implications 85
Relation of delayed intrinsicoid deflection of the QRS complex to sudden cardiac death in patients with hypertrophic cardiomyopathy 84
Outcome and disease progression in NYHA functional class I and II patients with wild-type transthyretin cardiomyopathy treated with tafamidis 84
Double duty: SGLT2 inhibitors as cardioprotective and anticancer allies 82
Arrhythmic risk stratification in patients with left ventricular ring-like scar 82
Progression and prognostic significance of electrocardiographic findings in patients with cardiac amyloidosis 81
Does the HFA/ICOS tool overestimate the risk of cardiovascular toxicities in oncologic patients scheduled to receive anti-VEGF agents? 79
Evaluation of the 2021 ESC recommendations for family screening in hereditary transthyretin cardiac amyloidosis 78
The diagnostic and prognostic value of the 12-lead ECG in arrhythmogenic left ventricular cardiomyopathy 77
Clinical presentations leading to arrhythmogenic left ventricular cardiomyopathy 77
Low QRS Voltages in Cardiac Amyloidosis. Clinical Correlates and Prognostic Value 76
Low Sensitivity of Bone Scintigraphy in Detecting Phe64Leu Mutation-Related Transthyretin Cardiac Amyloidosis 76
Clinical presentation, management, and in-hospital outcomes of acute coronary syndrome in active cancer patients vs. survivors 76
Cardiovascular risk profile and events before and after treatment with anti-VEGF drugs in the setting of a structured cardio-oncologic program 75
Current patterns of beta-blocker prescription in cardiac amyloidosis. an Italian nationwide survey 75
The American College of Cardology/American Heart Association heart failure staging system highlights diagnostic delay and predicts outcome in transthyretin cardiac amyloidosis 73
Urgent cesarean delivery following a spontaneous coronary artery dissection 72
Delayed left subclavian artery pseudoaneurysm following transcatheter aortic valve implantation 70
Clinical and prognostic implications of right ventricular uptake on bone scintigraphy in transthyretin amyloid cardiomyopathy 70
European society of cardiology core curriculum for cardio-oncology 69
The Diagnostic Value of the 12-Lead ECG in Arrhythmogenic Left Ventricular Cardiomyopathy. Novel ECG Signs 68
Change in prevalence of ATTR variants in Italy - Results from a National Survey 67
How Cardio-Oncology is called to prove its maturity 65
How to Monitor Cardiac Complications of Immune Checkpoint Inhibitor Therapy 65
Temporal Trend of Age at Diagnosis in Hypertrophic Cardiomyopathy. An Analysis of the International Sarcomeric Human Cardiomyopathy Registry 65
Cutaneous effects of antihypertensive drugs 64
Scar Architecture as a Structural Biomarker of Ventricular Arrhythmias and Sudden Cardiac Death in Patients with Hypertrophic Cardiomyopathy: a Cardiac Magnetic Resonance Study 63
Arterial Hypertension 63
Telehealth monitoring for hypertrophic cardiomyopathy and amyloid cardiomyopathy patients. Lessons from the coronavirus disease 2019 lockdown in Italy 62
Anterior mitral valve aneurysm is an uncommon complication of aortic valve infective endocarditis. A case report 62
Cardiac metastasis presenting with an ischaemic electrocardiogram pattern mimicking anterior myocardial infarction 60
Old and new therapeutic solutions in the treatment of hypertrophic cardiomyopathy 59
Cardiovascular safety of the tyrosine kinase inhibitor nintedanib 58
Recommendations for pre-symptomatic genetic testing for hereditary transthyretin amyloidosis in the era of effective therapy. a multicenter Italian consensus 56
The Need for Cardiovascular Risk Factor Prevention in Cardio-Oncology 55
Cardioembolic stroke in cardiac amyloidosis. the real challenge lies beyond heart rhythm 55
Letter regarding the article 'Heart failure with preserved ejection fraction. Frommechanisms to therapies' by Lamand colleagues 55
Real-world versus trial patients with transthyretin amyloid cardiomyopathy 55
Prognostic value of malnutrition, frailty, and physical performance in transthyretin cardiac amyloidosis: insights from a prospective multicenter cohort study 54
Prevalence of transthyretin amyloid cardiomyopathy in male patients who underwent bilateral carpal tunnel surgery. The ACTUAL study 53
Sudden death after valve-in-valve procedure due to delayed coronary obstruction. A case report 53
From the phenotype to precision medicine. an update on the cardiomyopathies diagnostic workflow 53
Totale 10.168
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.777
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.777
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022120 0 0 0 35 11 7 4 8 4 3 31 17
2022/2023372 19 24 13 16 33 26 29 17 25 65 77 28
2023/2024534 32 42 25 57 42 72 29 36 13 64 56 66
2024/20252.159 35 82 106 108 101 148 187 130 219 225 176 642
2025/20265.729 511 352 557 487 643 282 742 286 504 565 402 398
2026/20271.688 497 446 575 170 0 0 0 0 0 0 0 0
Totale 10.747